Lineage Cell Therapeutics In shares owned by Albion Financial Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Albion Financial Group
from 13F filings
Historical chart of Albion Financial Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Albion Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Albion Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.1k | 3.0k | 1.69 |
| 2025-06-30 | $2.8k | 3.0k | 0.91 |
| 2025-03-31 | $1.4k | 3.0k | 0.45 |
| 2024-12-31 | $1.5k | 3.0k | 0.50 |
| 2024-09-30 | $2.8k | 3.0k | 0.91 |
| 2024-06-30 | $3.0k | 3.0k | 1.00 |
| 2024-03-31 | $4.5k | 3.0k | 1.48 |
| 2023-12-31 | $3.3k | 3.0k | 1.09 |
| 2023-09-30 | $3.6k | 3.0k | 1.18 |
| 2023-06-30 | $4.3k | 3.0k | 1.41 |
| 2023-03-31 | $4.6k | 3.0k | 1.50 |
| 2022-12-31 | $3.6k | 3.0k | 1.17 |
| 2022-09-30 | $3.0k | 3.0k | 0.99 |
| 2022-06-30 | $5.0k | 3.0k | 1.64 |
| 2022-03-31 | $5.0k | 3.0k | 1.64 |
| 2021-12-31 | $7.0k | 3.0k | 2.30 |
| 2021-09-30 | $8.0k | 3.0k | 2.63 |
| 2021-06-30 | $9.0k | 3.0k | 2.96 |
| 2020-12-31 | $5.0k | 3.0k | 1.64 |